drugset / Trial / NCT00529490

Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats

NCT00529490

Phase 3 Completed 230 enrolled Innogene Kalbiotech Pte. Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective, randomized, open-label study to assess the efficacy and safety of hypertonic lactate solution, compared to Ringer's Lactate as fluid resuscitation to maintain hemodynamic stability in post-coronary artery bypass grafting(CABG) patients. Patients who were eligible received either hypertonic lactate solution or Ringer's Lactate post-CABG in the ICU when fluid resuscitation was needed.

Timeline

Start
2002-03
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic lactate Unknown 10 ml Other
Comparator Ringer's Lactate Other / unclassified 30 ml Other

Indications

No indication recorded.